Quantitative MIA-based assessment of c-CBL expression across the spectrum of secondary lymphoid tissue (reactive tonsil tissue, 5 cases), BIDs (47 cases), CTCL lesional skin (18 cases) and CTCL cell lines (5 distinct cell lines). * p < 0.05 as compared to tonsil, ** p < 0.05 as compared to tonsil as well as BIDs, *** p < 0.05 as compared to tonsil, BIDs and CTCL lesions.